P-MSC/TERT308 as model to optimize cellular cytotoxicity assays
P-MSC/TERT308 as model to optimize cellular cytotoxicity assay May 27th, 2025, Vienna, Austria We are pleased to share a new research note
By admin|2026-02-07T10:20:34+00:00May 27th, 2025|EU funded project, LifeSaver Project, Maternal and fetal health, mesenchymal stromal cells, telomerized cells|
P-MSC/TERT308 as model to optimize cellular cytotoxicity assay May 27th, 2025, Vienna, Austria We are pleased to share a new research note
By Evercyte|2021-11-25T20:37:23+00:00November 25th, 2021|Maternal and fetal health|
We are proud to announce our participation in the LIVESAVER project November 25, 2021, Vienna, Austria The LIFESAVER project addresses the
You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from OpenStreetMap. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information